rs7545855

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_182972.3(IRF2BP2):​c.232T>C​(p.Ser78Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.709 in 1,377,458 control chromosomes in the GnomAD database, including 352,861 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.73 ( 41039 hom., cov: 32)
Exomes 𝑓: 0.71 ( 311822 hom. )

Consequence

IRF2BP2
NM_182972.3 missense

Scores

1
17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 0.495

Publications

20 publications found
Variant links:
Genes affected
IRF2BP2 (HGNC:21729): (interferon regulatory factor 2 binding protein 2) This gene encodes an interferon regulatory factor-2 (IRF2) binding protein that interacts with the C-terminal transcriptional repression domain of IRF2. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Jul 2008]
LINC00184 (HGNC:37192): (long intergenic non-protein coding RNA 184)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=1.3392341E-6).
BP6
Variant 1-234609263-A-G is Benign according to our data. Variant chr1-234609263-A-G is described in ClinVar as [Benign]. Clinvar id is 402984.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.834 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
IRF2BP2NM_182972.3 linkc.232T>C p.Ser78Pro missense_variant Exon 1 of 2 ENST00000366609.4 NP_892017.2 Q7Z5L9-1
IRF2BP2NM_001077397.1 linkc.232T>C p.Ser78Pro missense_variant Exon 1 of 2 NP_001070865.1 Q7Z5L9-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
IRF2BP2ENST00000366609.4 linkc.232T>C p.Ser78Pro missense_variant Exon 1 of 2 1 NM_182972.3 ENSP00000355568.3 Q7Z5L9-1
IRF2BP2ENST00000366610.8 linkc.232T>C p.Ser78Pro missense_variant Exon 1 of 2 1 ENSP00000355569.3 Q7Z5L9-2
ENSG00000228830ENST00000436039.1 linkn.631-158A>G intron_variant Intron 1 of 1 3
LINC00184ENST00000796406.1 linkn.-32A>G upstream_gene_variant

Frequencies

GnomAD3 genomes
AF:
0.728
AC:
109668
AN:
150662
Hom.:
41000
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.842
Gnomad AMI
AF:
0.659
Gnomad AMR
AF:
0.622
Gnomad ASJ
AF:
0.749
Gnomad EAS
AF:
0.272
Gnomad SAS
AF:
0.487
Gnomad FIN
AF:
0.715
Gnomad MID
AF:
0.737
Gnomad NFE
AF:
0.735
Gnomad OTH
AF:
0.734
GnomAD2 exomes
AF:
0.610
AC:
11605
AN:
19032
AF XY:
0.611
show subpopulations
Gnomad AFR exome
AF:
0.760
Gnomad AMR exome
AF:
0.379
Gnomad ASJ exome
AF:
0.701
Gnomad EAS exome
AF:
0.178
Gnomad FIN exome
AF:
0.725
Gnomad NFE exome
AF:
0.696
Gnomad OTH exome
AF:
0.666
GnomAD4 exome
AF:
0.707
AC:
867342
AN:
1226686
Hom.:
311822
Cov.:
64
AF XY:
0.702
AC XY:
420732
AN XY:
599294
show subpopulations
African (AFR)
AF:
0.840
AC:
20255
AN:
24126
American (AMR)
AF:
0.517
AC:
6135
AN:
11870
Ashkenazi Jewish (ASJ)
AF:
0.746
AC:
12756
AN:
17100
East Asian (EAS)
AF:
0.278
AC:
7607
AN:
27382
South Asian (SAS)
AF:
0.499
AC:
27234
AN:
54596
European-Finnish (FIN)
AF:
0.718
AC:
27126
AN:
37798
Middle Eastern (MID)
AF:
0.731
AC:
2533
AN:
3466
European-Non Finnish (NFE)
AF:
0.729
AC:
729211
AN:
1000446
Other (OTH)
AF:
0.691
AC:
34485
AN:
49902
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
14644
29288
43933
58577
73221
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
19152
38304
57456
76608
95760
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.728
AC:
109756
AN:
150772
Hom.:
41039
Cov.:
32
AF XY:
0.718
AC XY:
52866
AN XY:
73584
show subpopulations
African (AFR)
AF:
0.842
AC:
34825
AN:
41372
American (AMR)
AF:
0.621
AC:
9443
AN:
15194
Ashkenazi Jewish (ASJ)
AF:
0.749
AC:
2580
AN:
3446
East Asian (EAS)
AF:
0.272
AC:
1357
AN:
4992
South Asian (SAS)
AF:
0.488
AC:
2339
AN:
4794
European-Finnish (FIN)
AF:
0.715
AC:
7402
AN:
10356
Middle Eastern (MID)
AF:
0.736
AC:
212
AN:
288
European-Non Finnish (NFE)
AF:
0.735
AC:
49477
AN:
67338
Other (OTH)
AF:
0.730
AC:
1525
AN:
2088
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
1422
2844
4265
5687
7109
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
812
1624
2436
3248
4060
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.732
Hom.:
4724
Bravo
AF:
0.723
ExAC
AF:
0.361
AC:
11334
Asia WGS
AF:
0.416
AC:
1389
AN:
3326

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Mar 29, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

Jan 24, 2024
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 72% of patients studied by a panel of primary immunodeficiencies. Number of patients: 68. Only high quality variants are reported. -

not provided Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Immunodeficiency, common variable, 14 Benign:1
Aug 19, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.047
BayesDel_addAF
Benign
-0.73
T
BayesDel_noAF
Benign
-0.68
CADD
Benign
7.2
DANN
Benign
0.13
DEOGEN2
Benign
0.0037
.;T
Eigen
Benign
-1.5
Eigen_PC
Benign
-1.5
FATHMM_MKL
Benign
0.0023
N
LIST_S2
Benign
0.17
T;T
MetaRNN
Benign
0.0000013
T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.34
N;N
PhyloP100
0.49
PrimateAI
Pathogenic
0.85
D
PROVEAN
Benign
1.8
N;N
REVEL
Benign
0.028
Sift
Benign
1.0
T;T
Sift4G
Benign
0.95
T;T
Polyphen
0.0
B;B
Vest4
0.048
MPC
1.5
ClinPred
0.0033
T
GERP RS
0.22
PromoterAI
-0.11
Neutral
Varity_R
0.099
gMVP
0.15
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7545855; hg19: chr1-234745009; COSMIC: COSV64014804; COSMIC: COSV64014804; API